# NASUS PHARMA LTD (NSRX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/NSRX/

- Reporting holders: 10
- Reported value: $7.6M
- Shares held by institutions: 2,172,415 of 9,015,383 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Balyasny Asset Management L.P.](https://holderbook.com/funds/1218710-balyasny-asset-management-l-p/) | $3.1M | 898,473 | 0.0% | 2 |
| [Cable Car Capital, LP](https://holderbook.com/funds/1699575-cable-car-capital-lp/) | $2.2M | 616,081 | 0.0% | 2 |
| [Velan Capital Investment Management LP](https://holderbook.com/funds/1848809-velan-capital-investment-management-lp/) | $1.3M | 359,390 | 0.8% | 2 |
| [Hudson Bay Capital Management LP](https://holderbook.com/funds/1393825-hudson-bay-capital-management-lp/) | $471.7K | 134,771 | 0.0% | 2 |
| [Bleichroeder LP](https://holderbook.com/funds/1781002-bleichroeder-lp/) | $314.5K | 89,848 | 0.1% | 2 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $154.0K | 44,008 | 0.0% | 1 |
| [XTX Topco Ltd](https://holderbook.com/funds/1828301-xtx-topco-ltd/) | $58.2K | 16,640 | 0.0% | 1 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $42.7K | 12,200 | 0.0% | 1 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $3.5K | 1,000 | 0.0% | 4 |
| [Caitong International Asset Management Co., Ltd](https://holderbook.com/funds/1963355-caitong-international-asset-management-co-ltd/) | $14 | 4 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 10 | $7.6M |
| Q1 2026 | 9 | $4.8M |
| Q4 2025 | 2 | $21.8K |
| Q3 2025 | 2 | $21.6K |